← Back to headlines
Dr Reddy's shares fall due to semaglutide supply issues
India's Dr Reddy's Laboratories is experiencing its worst trading day in three years following disruptions in the supply of semaglutide.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
